Published in N Engl J Med on February 10, 1983
Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. J Exp Med (2012) 3.17
Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood (2011) 3.02
Microbial translocation across the GI tract. Annu Rev Immunol (2012) 2.30
Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease. J Exp Med (1992) 2.16
Tumor necrosis factor- alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease. J Clin Invest (1998) 2.14
Inflammatory bowel disease in C.B-17 scid mice reconstituted with the CD45RBhigh subset of CD4+ T cells. Am J Pathol (1996) 2.03
LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation. J Clin Invest (2001) 1.91
Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia. J Clin Oncol (2008) 1.63
Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease. Biol Blood Marrow Transplant (2015) 1.19
Should methotrexate plus calcineurin inhibitors be considered standard of care for prophylaxis of acute graft-versus-host disease? Biol Blood Marrow Transplant (2009) 1.13
Value of serum C-reactive protein measurement in the management of bone marrow transplant recipients. Part I: Early transplant period. J Clin Pathol (1984) 1.10
The ever-expanding function of NOD2: autophagy, viral recognition, and T cell activation. Trends Immunol (2011) 1.09
Regulatory role of OX22high T cells in mercury-induced autoimmunity in the brown Norway rat. J Exp Med (1993) 1.01
Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice. Sci Transl Med (2016) 0.99
Gut toxicity during hemopoietic stem cell transplantation may predict acute graft-versus-host disease severity in patients. Dig Dis Sci (2007) 0.99
Complete suppression of the gut microbiome prevents acute graft-versus-host disease following allogeneic bone marrow transplantation. PLoS One (2014) 0.97
Allogeneic hematopoietic cell transplantation following minimal intensity conditioning: predicting acute graft-versus-host disease and graft-versus-tumor effects. Biol Blood Marrow Transplant (2013) 0.94
Recent advances in the treatment of graft-versus-host disease. Clin Med Res (2004) 0.92
Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with posttransplantation cyclophosphamide. Haematologica (2016) 0.91
The role of pattern-recognition receptors in graft-versus-host disease and graft-versus-leukemia after allogeneic stem cell transplantation. Front Immunol (2014) 0.86
Hospital infection control in hematopoietic stem cell transplant recipients. Emerg Infect Dis (2001) 0.85
Intestinal microbiota-related effects on graft-versus-host disease. Int J Hematol (2015) 0.84
Intestinal microbiome changes and stem cell transplantation: Lessons learned. Virulence (2016) 0.82
Graft-versus-host disease: a review. J R Soc Med (1987) 0.82
Acute graft-versus-host disease: inflammation run amok? J Clin Invest (2001) 0.81
Various forms of tissue damage and danger signals following hematopoietic stem-cell transplantation. Front Immunol (2015) 0.81
Allogeneic hematopoietic cell transplantation: from experimental biology to clinical care. J Cancer Res Clin Oncol (2004) 0.80
Cellular immune function monitoring after allogeneic haematopoietic cell transplantation: evaluation of a new assay. Clin Exp Immunol (2013) 0.79
Bone marrow transplantation: a review. J Natl Med Assoc (1989) 0.79
Role of gut flora after bone marrow transplantation. Nat Microbiol (2016) 0.78
The intestinal epithelial barrier: a therapeutic target? Nat Rev Gastroenterol Hepatol (2016) 0.78
Listeriolysin as a virulence factor in Listeria monocytogenes infection of neonatal mice and murine decidual tissue. Infect Immun (1991) 0.78
A review of the current status and techniques of allogeneic bone marrow transplantation for treatment of leukaemia. J Clin Pathol (1983) 0.78
The Gut Microbiota and Immune System Relationship in Human Graft-versus-Host Disease. Mediterr J Hematol Infect Dis (2016) 0.78
Antibiotic-mediated modification of the intestinal microbiome in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant (2016) 0.77
Possible implication of bacterial infection in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Front Oncol (2014) 0.76
Reduction in transplant-related complications in patients given intravenous immuno globulin after allogeneic marrow transplantation. Clin Exp Immunol (1994) 0.76
Role of the intestinal mucosa in acute gastrointestinal GVHD. Blood (2016) 0.75
Preparing the patient for bone marrow transplantation: nursing care issues. Yale J Biol Med (1991) 0.75
Allogeneic and autologous bone-marrow transplantation. Can Fam Physician (1988) 0.75
Antibiotic prophylaxis in allogeneic stem cell transplantation-what is the correct choice? Bone Marrow Transplant (2016) 0.75
Clinical Evidence for the Microbiome in Inflammatory Diseases. Front Immunol (2017) 0.75
The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease. Blood (2016) 0.75
Efficacy of azithromycin in preventing lethal graft-versus-host disease. Clin Exp Immunol (2013) 0.75
Disease severity and mortality can be independently regulated in a mouse model of experimental graft versus host disease. PLoS One (2015) 0.75
The use of immunoglobulin in bone marrow transplantation. J Clin Immunol (1990) 0.75
1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant (1995) 24.01
Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials (1989) 15.99
Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry (1988) 12.39
The analysis of failure times in the presence of competing risks. Biometrics (1978) 11.22
Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation (1974) 10.91
Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med (1995) 10.04
Opinion leaders vs audit and feedback to implement practice guidelines. Delivery after previous cesarean section. JAMA (1991) 9.71
Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med (1980) 9.64
Role-relationship models for case formulation. Arch Gen Psychiatry (1995) 5.87
Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med (2001) 5.59
Assessing health quality--the case for tracers. N Engl J Med (1973) 5.05
Regression analysis of grouped survival data with application to breast cancer data. Biometrics (1978) 5.05
Estimation of multiple relative risk functions in matched case-control studies. Am J Epidemiol (1978) 4.76
Solid cancers after bone marrow transplantation. N Engl J Med (1997) 4.62
Regression estimation using multivariate failure time data and a common baseline hazard function model. Lifetime Data Anal (1997) 4.47
A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology (1989) 4.27
Bone-marrow transplantation (second of two parts). N Engl J Med (1975) 4.11
Methylation of mouse liver DNA studied by means of the restriction enzymes msp I and hpa II. Science (1979) 4.06
Bone marrow transplantation for sickle cell disease. N Engl J Med (1996) 4.02
A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet (1979) 4.01
Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation. N Engl J Med (2001) 3.98
Mortality rates in displaced and resident populations of central Somalia during 1992 famine. Lancet (1993) 3.84
Diagnosis of iron-deficiency anemia in the elderly. Am J Med (1990) 3.77
Definition of a common leukocyte cell-surface antigen (Lp95-150) associated with diverse cell-mediated immune functions. J Immunol (1983) 3.70
Samarium-153-EDTMP biodistribution and dosimetry estimation. J Nucl Med (1993) 3.65
Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med (1979) 3.59
Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen). J Exp Med (1985) 3.48
Bone-marrow transplantation (first of two parts). N Engl J Med (1975) 3.33
Hormonal impact of the 17alpha-hydroxylase/C(17,20)-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer. Br J Cancer (2004) 3.32
Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis (1986) 3.31
Monoclonal antibodies to cytomegalovirus: rapid identification of clinical isolates and preliminary use in diagnosis of cytomegalovirus pneumonia. Infect Immun (1982) 3.22
Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med (1986) 3.22
Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol (1991) 3.21
Azathioprine in rheumatoid arthritis. Br Med J (1969) 3.14
Iron Metabolism. Heme Synthesis in Vitro by Immature Erythrocytes. Science (1949) 3.14
Identification of a human T lymphocyte surface protein associated with the E-rosette receptor. J Exp Med (1981) 3.06
Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood (1998) 3.06
Acute respiratory illness in the community. Frequency of illness and the agents involved. Epidemiol Infect (1993) 3.06
A randomized trial of a family physician intervention for smoking cessation. JAMA (1988) 3.03
Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood (1981) 3.03
Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial. N Engl J Med (1985) 2.99
Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant Proc (1974) 2.95
Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med (1993) 2.91
Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci U S A (1990) 2.88
Pathophysiology and treatment of graft-versus-host disease. Hematol Oncol Clin North Am (1999) 2.86
Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med (1993) 2.85
The canine major histocompatibility complex. Supertypic specificities defined by the primed lymphocyte test (PLT). Immunogenetics (1984) 2.72
Indications for marrow transplantation in chronic myelogenous leukemia. Blood (1989) 2.72
Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J Exp Med (1993) 2.71
Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. N Engl J Med (1990) 2.66
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood (1999) 2.65
Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis (1999) 2.65
The application of mitochondrial DNA typing to the study of white Caucasian genetic identification. Int J Legal Med (1993) 2.64
Regression calibration in failure time regression. Biometrics (1997) 2.61
Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. N Engl J Med (1981) 2.61
Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med (1989) 2.61
Antigen CD34+ marrow cells engraft lethally irradiated baboons. J Clin Invest (1988) 2.53
Nobel laureates' letter to President Bush. Washington Post (2001) 2.43
Heat-stable antigen is a costimulatory molecule for CD4 T cell growth. J Exp Med (1992) 2.42
Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med (1989) 2.42
Cell surface antigens of human melanoma identified by monoclonal antibody. Proc Natl Acad Sci U S A (1979) 2.40
Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experience. Rev Infect Dis (1983) 2.39
Development and testing of a new measure of health status for clinical trials in heart failure. J Gen Intern Med (1989) 2.39
One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood (1977) 2.36